Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Schering PEG-Intron/Rebetol Phase IV To Evaluate Alternate Dosing Regimen

Aug 20 2001

• By The Pink Sheet

Related Content

Risperdal Depot Formulation May Aid Compliance Among Schizophrenics

Apr 10 2000

Schering Rebetol

Jul 30 2001

Schering PEG-Intron Phase IV Trial To Study African Americans

Jan 29 2001

Peginterferon/Ribavirin Cost Balanced By Increased Efficacy - Schering

Apr 02 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window